Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma (Q44716307)

5 December 2017

Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma (English)

1 reference

5 December 2017

chronic liver disease

0 references

author name string

Miho Ichiba

1

1 reference

5 December 2017

Yoshiko Maeta

2

1 reference

5 December 2017

Tomoyuki Mukoyama

3

1 reference

5 December 2017

Toshiya Saeki

4

1 reference

5 December 2017

Sakiko Yasui

5

1 reference

5 December 2017

Takamasa Kanbe

6

1 reference

5 December 2017

Jun-Ichi Okano

7

1 reference

5 December 2017

Yoshinao Tanabe

8

1 reference

5 December 2017

Yasuaki Hirooka

9

1 reference

5 December 2017

Sadako Yamada

10

1 reference

5 December 2017

Akihiro Kurimasa

11

1 reference

5 December 2017

Yoshikazu Murawaki

12

1 reference

5 December 2017

Goshi Shiota

13

1 reference

5 December 2017

1 October 2003

1 reference

5 December 2017

1 reference

5 December 2017

23

1 reference

5 December 2017

5

1 reference

5 December 2017

338-345

1 reference

Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis

5 December 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Effects of reactive oxygen species on proliferation of Chinese hamster lung fibroblast (V79) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2'-deoxyguanosine formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Increased hepatic oxidative DNA damage in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Association between reactive oxygen species and disease activity in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Interferon decreases serum lipid peroxidation products of hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Catalase activity in human hepatocellular carcinoma (HCC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

7 January 2021

Hydroxyl free radical mediated formation of 8-hydroxyguanine in isolated DNA

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

7 January 2021

Histologic prognostic indicators in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

7 January 2021

Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

7 January 2021

Decreased activity of liver glutathione peroxidase in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

7 January 2021

Detection of occult low-grade B-cell non-hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

7 January 2021

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00868.X

7 January 2021

10.1034/J.1478-3231.2003.00868.X

Identifiers

DOI

1 reference

5 December 2017

1 reference